Abstract
This month we focus on papers that provide insights into the potential for target trial emulation to be used in health technology assessment, the role of real-world evidence (RWE) in informing additional elements of value and the importance of RWE to European joint clinical assessments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have